Publications Publication Systematic in silico analysis of clinically tested drugs for reducing amyloid-beta plaque... Published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association Disease Area Neuroscience Modality Multiple View Details Publication Collaboration Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A... Collaboration with KSQ Therapeutics - Published in CPT: Pharmacometrics Systems Pharmacology Disease Area Immuno-oncology Modality mAb View Details Publication Collaboration Model-Informed Drug Development of the Masked Anti-PD-L1 Antibody CX-072 Collaboration with CytomX Therapeutics - Published in Clinical Pharmacology & Therapeutics Disease Area Oncology Modality mAb View Details Publication Mechanistic PKPD Models of Protein Therapeutics for Early Clinical Development Published in AAPS Newsmagazine Disease Area Multiple Modality Multiple View Details Publication Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of... Published in Clinical Pharmacology & Therapeutics Disease Area Oncology Modality Bispecific View Details Publication Collaboration Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome:... Collaboration with MIT - Published in Research and Practice in Thrombosis and Haemostasis Disease Area Virology Modality Other View Details Publication Collaboration QSP Model of Colonic Motility Collaboration with Takeda - Published in Journal of Pharmacokinetics and Pharmacodynamics Disease Area Inflammation and Immunology Modality Small Molecule View Details Publication Collaboration QSP Model of a Masked, Tumor-Activated Antibody Collaboration with CytomX Therapeutics - Published in CPT: Pharmacometrics & Systems Pharmacology Disease Area Oncology Modality mAb View Details Publication Model Firsts: How QSP can Pick the Right Dose for First-in-Human Trials Published in BioCentury Innovations Disease Area Multiple Modality Multiple View Details Publication Collaboration QSP Model of modRNA to Treat Crigler-Najjar Syndrome Type 1 Collaboration with Alexion Pharmaceuticals - Published in CPT: Pharmacometrics & Systems Pharmacology Disease Area Rare Disease Modality Lipid Nanoparticle View Details Pagination First Previous Page 1 Current page 2